Studies have pointed out that IgA-binding tumor antigens can mediate the transcytosis and cytosis, promoting cytotoxic T lymphocyte (CTL) killing of tumor cells and inhibiting tumor growth in ovarian cancer through myeloid cell-dependent mechanisms, neutralizing secreted factors, or poly-Ig receptors on cancer cells 60. The gene discussed is CD79A; the disease is ovarian carcinoma.